Pfizer
Kevin Nepveux has a work experience in the pharmaceutical company Pfizer. Kevin has held various roles, including Vice President of Manufacturing and Vice President of Pfizer Global Supply - Launch Excellence. Kevin has also served as Vice President of Global Manufacturing Services. The exact start and end dates for their roles are not provided.
Kevin Nepveux has a Bachelor of Science in Chemical Engineering from the University of Delaware, which they obtained from 1976 to 1980. Kevin also holds a Master of Science in Computer Science from Rensselaer Polytechnic Institute, completed from 1983 to 1986.
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.